Search Results for: "National Cancer Institute"

Early Antiretroviral Therapy Prevents Non-Aids Outcomes in HIV-Infected People, NIH-Supported Study Finds

NIH logo

New Findings Illustrate Manifold Benefit of Therapy Starting antiretroviral therapy early not only prevents serious AIDS-related diseases, but also prevents the onset of cancer, cardiovascular disease, and other non-AIDS-related diseases in HIV-infected people, according to a new analysis of data from the Strategic Timing of AntiRetroviral Treatment (START) study, the first large-scale randomized clinical trial to…

Starting antiretroviral treatment early improves outcomes for HIV-infected individuals

nih logo

For Immediate Release: Wednesday, May 27, 2015 NIH-funded trial results likely will impact global treatment guidelines A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune…

NIH, South African Medical Research Council award $8 million in HIV, TB grants

nih logo

The National Institutes of Health and the South African Medical Research Council (SAMRC) are awarding 31 grants to U.S. and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers. The awards, which total $8 million in first-year funding, are the first to be issued through the South Africa–U.S. Program for…

NIH Seeks Applications for HIV and Viral Hepatitis Co-Infection Research Funding

Ronald Valdiserri

The National Institutes of Health (NIH) recently released two funding opportunity announcements (FOAs) to support multidisciplinary studies of HIV and viral hepatitis co-infection. The opportunities were issued under NIH’s R01 or Research Project Grant program and R21 or Exploratory/Developmental Research Grant program. NIH notes that the FOAs were informed by priority areas in the Action…

NIH’s Dr. Carl Dieffenbach Shares Highlights from CROI 2014 – March 4

Carl Dieffenbach at CROI

Yesterday, March 4, was the first full day of the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston. Over 4,000 HIV/AIDS research leaders from 85 countries are gathered at the annual scientific meeting discussing their work to understand, prevent, and treat HIV/AIDS and related infectious diseases. We’ve invited our colleague Dr. Carl Dieffenbach to…

NIH Observes 20th Anniversary of Women’s Interagency HIV Study


The largest and longest-running study to investigate the impact of HIV on women in the United States marks its 20th anniversary this month. Findings from the Women’s Interagency HIV Study (WIHS) have helped define how best to treat HIV-infected women in the United States and globally. The National Institute of Allergy and Infectious Diseases (NIAID),…

Highlights from The Liver Meeting

Corinna Dan

Every fall, hepatitis and liver disease experts gather to share the latest viral hepatitis research and treatment updates at the Liver MeetingTM . I had the opportunity to attend this year’s meeting, held last month in Boston. The meeting was particularly exciting because it featured new information about many novel hepatitis C treatments currently in…

NIH Leadership at the XIX International AIDS Conference

Dr. Jack Whitescarver

The hosting of the XIX International AIDS Conference in our nation’s capital, Washington, DC, is a tremendous opportunity to reflect on how AIDS has affected the United States, and how the United States has worked to reduce the impact of the epidemic in the U.S. and around the world. The first cases of what we…